APA (7th ed.) Citation

Kong, B., Wu, W., Cheng, T., Schlitter, A. M., Qian, C., Bruns, P., . . . Michalski, C. (2016). A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling. Gut, 65(4), . https://doi.org/10.1136/gutjnl-2014-307616

Chicago Style (17th ed.) Citation

Kong, Bo, et al. "A Subset of Metastatic Pancreatic Ductal Adenocarcinomas Depends Quantitatively on Oncogenic Kras/Mek/Erk-induced Hyperactive MTOR Signalling." Gut 65, no. 4 (2016). https://doi.org/10.1136/gutjnl-2014-307616.

MLA (9th ed.) Citation

Kong, Bo, et al. "A Subset of Metastatic Pancreatic Ductal Adenocarcinomas Depends Quantitatively on Oncogenic Kras/Mek/Erk-induced Hyperactive MTOR Signalling." Gut, vol. 65, no. 4, 2016, https://doi.org/10.1136/gutjnl-2014-307616.